# Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

> **NCT02596620** · NA · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 164 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Nexium
- **DRUG:** Amolin
- **DRUG:** Cravit
- **DRUG:** Flagyl

## Key facts

- **NCT ID:** NCT02596620
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-11
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2017-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02596620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02596620, "Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02596620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*